ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

SAMEERA FAREED FARRUKH M.D.

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,785Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 49

$479K Total Retail Price of All Prescriptions

Rank: 9 out of 49

282 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wyoming
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 282 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 5,463 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wyoming
LEVOTHYROXINE SODIUM 472 390 1 1
LISINOPRIL 349 250 2 3
WARFARIN SODIUM 274 145 3 8
AMLODIPINE BESYLATE 268 231 4 6
SIMVASTATIN 252 167 5 2
METFORMIN HCL 236 150 6 10
FUROSEMIDE 218 157 7 5
METOPROLOL TARTRATE 202 152 8 11
OMEPRAZOLE 192 139 9 4
ATORVASTATIN CALCIUM 174 127 10 13
HYDROCHLOROTHIAZIDE 152 96 11 12
METOPROLOL SUCCINATE 150 113 12 16
CITALOPRAM HBR 149 99 13 18
CRESTOR 146 97 14 23
SPIRIVA 132 89 15 37
HYDROCODONE-ACETAMINOPHEN 125 113 S3 16 7
POTASSIUM CHLORIDE 125 76 16 9
ATENOLOL 110 95 18 17
ZOLPIDEM TARTRATE 102 77 19 19
NEXIUM 82 50 20 27
CYMBALTA 75 57 21 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 59 22 34
SPIRONOLACTONE 68 38 23 26
LOSARTAN POTASSIUM 68 60 23 14
PRAVASTATIN SODIUM 66 46 25 20
ADVAIR DISKUS 65 40 26 28
SERTRALINE HCL 63 23 27 22
PROAIR HFA 57 44 28 58
LOSARTAN-HYDROCHLOROTHIAZIDE 55 52 29 40
SYNTHROID 54 23 30 45
PREMARIN 54 23 R 30 119
JANUVIA 53 28 32 44
TRAMADOL HCL 52 49 33 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.